fda compounding semaglutide news today 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Best Semaglutide Options for 2026:

3- Alpha-synuclein, LRRK2 and GBA are emerging as some of the most important biologic targets in the pipeline

Semaglutide alone achieves 1015% body weight loss, while dual-pathway GLP-1/GIP agents (tirzepatide) reach 20% in clinical trials

May be covered for Type 2 Diabetes under provincial drug plan Frequently Asked Questions How much does Ozempic cost in Canada

For weight management, eligible Medicare beneficiaries may qualify for the Medicare GLP-1 Bridge program with a prescription and prior authorization submitted by their healthcare provider

Pregnant or breastfeeding women, individuals with liver or kidney disease, and those taking multiple medications should exercise particular caution